Clinical Study

Mortality and Recovery of Renal Function in Acute Kidney Injury Patients Treated with Prolonged Intermittent Hemodialysis Sessions Lasting 10 versus 6 Hours: Results of a Randomized Clinical Trial

Table 5

Univariate logistic regression of clinical and laboratory characteristics, and dialysis complications associated with the death of patients with AKI treated with PHD.

ParameterORConfidence Intervalp value

Age1.010.99 – 1.030.24
Gender0.600.28 – 1.280.19
Weight1.011.00 – 1.030.04
Infectious focus0.950.33 – 2.700.87
SAH0.840.40 – 1.750.64
DM0.730.31 – 1.740.48
CKD0.220.02 – 1.760.15
ATN-ISS0.940.11- 7.980.95
SOFA1.221.06 – 1.400.004
Pre FB1.471.12 – 1.930.004
Post FB1.381.11 – 1.720.003
Pre Ur0.990.99 – 1.00.15
Post Ur1.000.99 – 1.010.67
Pre Cr1.010.80 – 1.280.88
CR post0.940.60 – 1.470.78
Pre K1.791.18 – 2.730.006
Post K1.820.82 – 4.000.13
Pre Bic0.930.85 – 1.010.11
Post Bic0.900.75 – 1.080.27
Pre UF0.930.78 – 1.120.49
Post UF0.860.67 – 1.120.28
RF outcome1.0<0,001 - >999,9990.85
Hypotension0.500.23 – 1.090.008
Coagulation0.760.34 – 1.700.5
Hypokalemia3.71.62 – 8.830.002
Hypophosphataemia1.480.66 - 3.310.33

Or: odds ratio.
AKI: acute renal injury, PHD: prolonged hemodialysis, SAH: systemic arterial hypertension, DM: diabetes mellitus, CKD: chronic kidney disease, ATN-ISS: acute tubular necrosis individual severity score, SOFA: sequential organ failure assessment score, FB: fluid balance, Ur: urea, Cr: creatinine, K: potassium, Bic: bicarbonate, UF: ultrafiltration, and RF: renal function. Pre = 1st session, post = 3rd session of PHD.